Recent examples of kinase inhibitors targeting cancer-associated immune cells include small molecule inhibitors directed towards Bruton’s tyrosine kinase (BTK) [111], colony-stimulating factor-1 receptor (CSF-1R) [112], and PI3Kgamma [113]. This evidence concerns the gene BTK and cancer.